Covestor’s Clover Health Investments CLOV Stock Holding History

Covestor’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	157 +111	+241%	+$377	﹤0.01%	2089
2026 Q1	$0	Buy	+46	New	+$100	﹤0.01%	2317

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Covestor's CLOV Position: Q2 2026 in Review

Covestor increased its Clover Health Investments (CLOV) stake by 241% in Q2 2026, buying an estimated $377 and bringing the position to 157 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Covestor first reported a position in CLOV in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Covestor held 157 shares of Clover Health Investments worth $1K as of Q2 2026.
Covestor bought 111 Clover Health Investments shares in Q2 2026, an estimated $377.
Clover Health Investments made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2089 holding.
Covestor first reported a position in Clover Health Investments in Q1 2026 and has held it in 2 quarters since.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.